1. Tess O’Meara, MD, MHS, Department of Medical Oncology, Yale School of Medicine, New Haven, CT, and Department of Medicine, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA; and Lajos Pusztai, MD, DPhil, Department of Medical Oncology, Yale School of Medicine, New Haven, CT